Site icon Market Globalist

Amryt (AMYT) Stock Is Declining Before Market Open, I Wonder Why?

Online shopping & business icon on retro computer keyboard

The price of Amryt Pharma plc (NASDAQ:AMYT) shares were down -8.88% to $11.7 at last check in premarket trading. AMRYT stock closed at $12.84 on Tuesday, down 5.24% or $0.71. Over the last session, the AMYT stock fluctuated between $12.84 and $13.365. Even after an acquisition announcement, AMYT stock is on the decline.

The acquisition deal is for what?

The Amryt Sciences Corporation is a global biopharmaceutical company focused on the acquisition, development, and commercialization of new therapeutics for the treatment of rare diseases.

How AMYT will leverage the deal?

With the right infrastructure, expertise and financial flexibility in place, Amryt (AMYT) is well prepared to take full advantage of the global potential of MYCAPSSA, the first and only oral somatostatin analog (“SSA”) approved for appropriate patients with acromegaly. AMYT anticipates accelerating its growing revenue and delivering estimated cost synergies of $50 million per year after the transaction.

Exit mobile version